Compound Detail
CHEMBL4757904
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4757904 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ITMQOKBFZDOCGE-UHFFFAOYSA-N |
7
Targets
7
Activities
1
Assay Types
0
PK Parameters
10
Publications
0
Known Names
Molecular Properties
510.1
MW (Da)
4.80
ALogP
6
HBA
1
HBD
61.4
PSA (Ų)
0.52
QED
1
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 7 meas. best 7.47
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | IC50 | 7.47 | 7.47 | 34.0 | 1 |
| Huh-7 CHEMBL614039 | IC50 | 7.12 | 7.12 | 76.0 | 1 |
| RAC-gamma serine/threonine-protein kinase CHEMBL4816 | IC50 | 6.89 | 6.89 | 129.0 | 1 |
| Hep 3B2 CHEMBL4296437 | IC50 | 6.88 | 6.88 | 131.0 | 1 |
| HepG2 CHEMBL395 | IC50 | 6.74 | 6.74 | 183.0 | 1 |
| SMMC-7721 CHEMBL613831 | IC50 | 6.41 | 6.41 | 386.0 | 1 |
| RAC-beta serine/threonine-protein kinase CHEMBL2431 | IC50 | 5.77 | 5.77 | 1710.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 34.0 | nM | 7.47 | Inhibition of full length human Akt1 S478G mutant using GRPRTSSFAEGKK as substra... | 32007668 |
| Huh-7 | IC50 | = | 76.0 | nM | 7.12 | Cytotoxicity against human Huh-7 cells assessed as reduction in cell viability b... | 32007668 |
| RAC-gamma serine/threonine-protein kinase | IC50 | = | 129.0 | nM | 6.89 | Inhibition of full length human Akt3 S472D mutant using GRPRTSSFAEGKK as substra... | 32007668 |
| Hep 3B2 | IC50 | = | 131.0 | nM | 6.88 | Cytotoxicity against human Hep3B cells assessed as reduction in cell viability b... | 32007668 |
| HepG2 | IC50 | = | 183.0 | nM | 6.74 | Cytotoxicity against human HepG2 cells assessed as reduction in cell viability b... | 32007668 |
| SMMC-7721 | IC50 | = | 386.0 | nM | 6.41 | Cytotoxicity against human SMMC-7721 cells assessed as reduction in cell viabili... | 32007668 |
| RAC-beta serine/threonine-protein kinase | IC50 | = | 1710.0 | nM | 5.77 | Inhibition of full length human Akt2 S474D mutant using GRPRTSSFAEGKK as substra... | 32007668 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 32007668 | 10.1016/j.ejmech.2020.112076 | Huh-7 | 36 |
| 32007668 | 10.1016/j.ejmech.2020.112076 | Unchecked | 5 |
| 32007668 | 10.1016/j.ejmech.2020.112076 | RAC-beta serine/threonine-protein kinase | 2 |
| 32007668 | 10.1016/j.ejmech.2020.112076 | RAC-gamma serine/threonine-protein kinase | 2 |
| 32007668 | 10.1016/j.ejmech.2020.112076 | Hep 3B2 | 2 |
| 32007668 | 10.1016/j.ejmech.2020.112076 | cAMP-dependent protein kinase catalytic subunit alpha | 1 |
| 32007668 | 10.1016/j.ejmech.2020.112076 | HepG2 | 1 |
| 32007668 | 10.1016/j.ejmech.2020.112076 | SMMC-7721 | 1 |
| 32007668 | 10.1016/j.ejmech.2020.112076 | Serine/threonine-protein kinase AKT | 1 |
| 32007668 | 10.1016/j.ejmech.2020.112076 | Glycogen synthase kinase-3 beta | 1 |
Data from ChEMBL 36 via Core Engine